| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $204.9M | — | +69.6% |
| Cost of Revenue | $33.5M | — | +115.6% |
| R&D Expense | $48.4M | — | +4.4% |
| SG&A Expense | $88.2M | — | +75.3% |
| Operating Income | $34.8M | — | +303.6% |
| Pre-tax Income | $20.4M | — | +272.4% |
| Income Tax | $586K | — | +43.6% |
| Net Income | $19.8M | — | +290.8% |
| EPS (Basic) | $0.14 | — | +366.7% |
| EPS (Diluted) | $0.12 | — | +300.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $442.2M | +458.7% | +234.7% |
| Short-term Investments | $72.2M | +15.0% | -49.9% |
| Accounts Receivable | $392.0M | +28.3% | +106.2% |
| Inventory | $129.0M | +2.7% | -18.2% |
| Current Assets | $1.09B | +72.3% | +68.7% |
| Total Assets | $1.53B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.9M | — | +37.7% |
| Capital Expenditures | $51K | — | +104.0% |
| Investing Cash Flow | -$9.9M | — | +23.7% |
| Financing Cash Flow | $390.8M | — | +6504.9% |
| Free Cash Flow | -$17.9M | — | +37.6% |
| +132.8% |
| Current Liabilities | $187.1M | +21.7% | +16.8% |
| Long-term Debt | $745.1M | +203.3% | +204.5% |
| Total Liabilities | $945.7M | +127.8% | +125.5% |
| Stockholders' Equity | $583.1M | -10.0% | +145.7% |